Nvidia has partnered with Johnson & Johnson to develop new AI applications to help doctors perform surgery.
Tags: Johnson & Johnson
Johnson & Johnson Plans Bankruptcy Filing to Finalize $6.48 Billion Talc Settlement
Johnson & Johnson is nearly announcing a $6.48 billion settlement to resolve talc-related cancer claims, with at least 75% of claimants supporting the deal. He plans to use a bankruptcy strategy to settle all current and future claims.
Johnson & Johnson Faces Fresh Lawsuit Seeking Damages, Cancer Monitoring for Talc Product Users
Johnson & Johnson is facing a new class action lawsuit seeking damages and medical monitoring for women potentially affected by cancer allegedly linked to the company's talc products.
Johnson & Johnson Ordered to Pay an Oregon Woman $260 Million After Getting Cancer Using the Powder
The 48-year-old Oregon woman claimed that she's been using Johnson & Johnson powder for 30 years and has been inhaling asbestos in return, but Johnson & Johnson maintained that their products do not contain such and do not cause cancer.
Johnson & Johnson Accused of 'Fraudulent' Delays in Talc Powder Cancer Cases
A new class action lawsuit accuses Johnson & Johnson of using fraudulent bankruptcy maneuvers to delay court trials for cancer claims related to its talc-based baby powder, preventing victims from seeking justice.
Latest News
It's no longer unusual if you see working mothers in the office, streets, or restaurants. With the high cost of living, children's education, and bills to pay, couples should help each other to make both ends meet.
With an objective of taking additive manufacturing (3-D printing) to further advance level, America Makes has drawn up plans to support research and development (R&D) with financial funding of up to $8 million.
International Business Machines Corp, deepening its partnership with Apple Inc to make use of health information gathered by millions of Apple devices, is creating a unit dedicated to providing data analytics to the healthcare sector.
Belgian biotech group Galapagos said on Tuesday that its research partner Janssen Pharmaceutica, a unit of Johnson & Johnson, had pulled out of a program to develop a new drug to treat bowel disease.
U.S. medical device maker Medtronic (MDT.N) gained European Union regulatory approval on Friday for its $43 billion takeover of Covidien Plc (COV.N) after agreeing to sell its Irish rival's drug-coated balloon catheter business.
Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp, Johnson & Johnson finally has a chance for payback at a multibillion-dollar trial set to begin on Thursday.
Johnson & Johnson (JNJ.N) agreed to pay $1.75 billion in cash to buy privately held Alios BioPharma Inc, which is developing a drug for a common respiratory viral infection in children for which there is no approved treatment.
Johnson & Johnson (JNJ.N) plans to seek a buyer for its medical device maker business, Cordis Corp, The Wall Street Journal reported citing people familiar with the matter.
International Business Machines Corp on Wednesday launched a computer system that can quickly identify patterns in massive amounts of data, an ability that IBM said should hasten breakthroughs in science and medical research.
